Drugs and Drug Candidates

MDPI AG

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Drugs and Drug Candidates is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
MDPI AG
ISSN
2813-2998
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,000 CHF
Articles in DOAJ
178
Declared review time
6 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2023-08-04
Indexing
DOAJ
APC
1,000 CHF
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

178

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

195

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

16

i10-index

27

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2023-08-04
Added to DOAJ
2023-08-04
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
94%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918787563406676
Classification4

Subjects (DOAJ)

Medicine: Pharmacy and materia medicaScience: Chemistry

LCC codes

RS1-441QD1-999

Subject areas

  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Essential Oils and Antimicrobial Activity
  • Essential Oils and Antimicrobial Activity
  • Natural product bioactivities and synthesis
  • Natural product bioactivities and synthesis
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Traditional and Medicinal Uses of Annonaceae
Show all subjects (50)
  • Pharmacological Effects of Natural Compounds
  • Research on Leishmaniasis Studies
  • SARS-CoV-2 and COVID-19 Research
  • Synthesis and biological activity
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • SARS-CoV-2 and COVID-19 Research
  • Research on Leishmaniasis Studies
  • Bioactive Compounds and Antitumor Agents
  • Synthesis and biological activity
  • Pharmacological Effects of Natural Compounds
  • Traditional and Medicinal Uses of Annonaceae
  • Bioactive Compounds and Antitumor Agents
  • Natural Antidiabetic Agents Studies
  • Antibiotic Resistance in Bacteria
  • Bacteriophages and microbial interactions
  • Trypanosoma species research and implications
  • Monoclonal and Polyclonal Antibodies Research
  • Natural Antidiabetic Agents Studies
  • Cholinesterase and Neurodegenerative Diseases
  • Cannabis and Cannabinoid Research
  • Antibiotic Resistance in Bacteria
  • Bacteriophages and microbial interactions
  • HIV/AIDS drug development and treatment
  • Cannabis and Cannabinoid Research
  • Monoclonal and Polyclonal Antibodies Research
  • Trypanosoma species research and implications
  • Cholinesterase and Neurodegenerative Diseases
  • Nanoparticles: synthesis and applications
  • Microbial Natural Products and Biosynthesis
  • Nanoparticles: synthesis and applications
  • Cancer therapeutics and mechanisms
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Protein Degradation and Inhibitors
  • Microbial Natural Products and Biosynthesis
  • Pharmacogenetics and Drug Metabolism
  • HIV/AIDS drug development and treatment
  • Cancer therapeutics and mechanisms
  • Protein Degradation and Inhibitors
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Pharmacogenetics and Drug Metabolism
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies

Keywords (DOAJ)

  • marketed drugs
  • drugs
  • drug industry
  • pharmacology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: